WallStreetZenWallStreetZen

NASDAQ: IPA
Immunoprecise Antibodies Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Immunoprecise Antibodies earnings were -$22.1M for the trailing 12 months ending Apr 30, 2025, with N/A growth year over year. The latest IPA earnings report on Apr 30, 2025 announced Q2 2025 earnings of -$1.6M, down 89.5% from last quarter. For the last reported fiscal year 2025 ending Apr 30, 2025, IPA reported annual earnings of -$21.9M, with 15.8% growth.

IPA earnings history

Current Revenue
$17.8M
Current Earnings
-$21.9M
Current Profit Margin
-123.3%

IPA Return on Equity

Current Company
-105.8%
Current Industry
-60.2%
Current Market
31.3%
IPA's Return on Equity (-105.8%)... subscribe to Premium to read more.
High Return on Equity Performance

IPA undefined

Current Company
-57.8%
Current Industry
-2.5%
IPA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IPA announces earnings.

IPA undefined

Current Company
-95.92%
Current Industry
5.8%
IPA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IPA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IPA-$21.06M-$22.07MN/A-$0.66
TARA-$50.52M-$50.86MN/A-$1.57
CHRS-$106.54M-$130.94MN/A-$1.13
OTLK-$43.25M-$43.44MN/A-$0.57
PLX$10.55M$6.28M-10.56%$0.08
View Top Biotech Stocks

Immunoprecise Antibodies Earnings Reports & History FAQ

What were Immunoprecise Antibodies's earnings last quarter?

On IPA's earnings call on Invalid Date, Immunoprecise Antibodies (NASDAQ: IPA) reported Q1 2025 earnings per share (EPS) of -$0.04, up 92.47% year over year. Total IPA earnings for the quarter were -$1.57 million. In the same quarter last year, Immunoprecise Antibodies's earnings per share (EPS) was -$0.48.

If you're new to stock investing, here's how to buy Immunoprecise Antibodies stock.

Is Immunoprecise Antibodies profitable or losing money?

As of the last Immunoprecise Antibodies earnings report, Immunoprecise Antibodies is currently losing money. Immunoprecise Antibodies's net profit (also called net income) for the twelve months ending Apr 30, 2025 was -$21.91 million, a 15.77% increase year over year.

What was IPA's earnings growth in the past year?

As of Immunoprecise Antibodies's earnings date in Invalid Date, Immunoprecise Antibodies's earnings has grown year over year. IPA earnings in the past year totalled -$22.07 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.